Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
52.75%
-
Total 13F principal
-
$199,921,591
-
Principal change
-
+$199,921,591
-
Total reported market value
-
$115,537,000
-
Number of holders
-
17
-
Value change
-
+$115,537,632
-
Number of buys
-
17
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2021
As of 31 Dec 2021,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
17 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$199,921,591
in principal (par value) of the bond.
The largest 10 bondholders included
Pentwater Capital Management LP, LAZARD ASSET MANAGEMENT LLC, Davidson Kempner Capital Management LP, WHITEBOX ADVISORS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, Point72 Asset Management, L.P., and BlueCrest Capital Management Ltd.
This page lists
17
institutional bondholders reporting positions
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.